Clinical Study

Long-Term, Open-Label, Flexible-Dose, Extension Study Of Vortioxetine In Child And Adolescent Patients With Major Depressive Disorder (Mdd)

Posted Date: Jan 14, 2020

  • Investigator: Melissa Delbello
  • Specialties: Adolescent Psychiatry/Psychology, Depression, Psychiatry/Psychology
  • Type of Study: Drug

The goal of this study is to evaluate the long-term safety and efficacy of an investigational medication in children with depression. This study is open-label, which means that all participants will receive the medication (vortioxetine) for up to 6 months.

Criteria:

Children Who Completed The 12 Week Lead In Study. (12709A Roll-Over Participant)

Keywords:

Major Depressive Disorder, Depression, Children

For More Information:

Kelsey Reinhart, M.S
(513) 558-3952
reinhakt@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.